Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Diabetes. 2022 Mar 1;71(3):530–537. doi: 10.2337/db21-0517

Figure 3.

Figure 3

Comparison of clinical features in patients with HNF1B diabetes diagnosed by unselected testing using tNGS and by clinically suspected testing using Sanger sequencing and MLPA analysis undertaken as requested by the referring clinician. Filled bars are patients with an HNF1B mutation identified by targeted NGS in a suspected MODY cohort and non-filled bars are patients with an HNF1B mutation identified when clinically suspected of having HNF1B-related disease.